1-3 of 3
Pia Petrini, MD
Close
Sort by
Journal Articles

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Yasmina L. Abajas, MD, Paul Edward Monahan, MD, Brenda Nielsen, RN, Pia Petrini, MD, Susanna Ranta, MD PhD, Geoffrey A. Allen, MD, Silvia Horneff, MD, Annika Martensson, MD PhD, Johannes Oldenburg, MD PhD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 1193.
https://doi.org/10.1182/blood-2018-99-120141
Published: 2018
Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Maria Elisa Mancuso, MD PhD, Kathelijn Fischer, MD PhD MSc, Elena Santagostino, MD PhD, Johannes Oldenburg, Prof, Helen Platokouki, MD, Christoph Königs, MD PhD, Carmen Escuriola, MD, Georges-Etienne Rivard, MD, Ana Cid, MD, Manuel Carcao, MD, Rolf Ljung, MD PhD, Pia Petrini, MD, Anne Rafowicz, MD, Carmen Altisent, MD, Gili Kenet, MD, Raina Liesner, Karin Kurnik, MD, Christel Van Geet, MD PhD, Teresa Alvarez-Roman, MD, Tin Tin Yee, MD, Guenter Auerswald, Sr., MD, Rosario Perez-Garrido, MD, Beatrice Nolan, Hervé Chambost, Anne Makipernaa, MD, Angelo Claudio Molinari, MD, Angela Thomas, MBBS, PhD, Elizabeth Chalmers, MD, Mike Williams, MD, Rainer Kobelt, MD, Marijke Van den Berg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3774.
https://doi.org/10.1182/blood.V128.22.3774.3774
Published: 2016
Journal Articles

Risk of Thrombosis with Different Approaches to Central Venous Access During Acquired Asparaginase Related Antithrombin Deficiency in Children with Leukemia.

Susanna Ranta, MD, PhD, Mats Heyman, MD, PhD, Kirsi Jahnukainen, MD, PhD, Mervi Taskinen, MD, PhD, Ulla M. Saarinen-Pihkala, Tony Frisk, MD, PhD, Stefan Söderhäll, MD, PhD, Pia Petrini, MD, Anne Mäkipernaa, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2241.
https://doi.org/10.1182/blood.V120.21.2241.2241
Published: 2012